Comparison of Thick Biolimus A9-Eluting Stent and Thin Zotarolimus-Eluting Stent in Multi-Vessel Percutaneous Coronary Intervention
Authors:
- Cheol Hyun LeeCLCheol Hyun Lee
- Hee Jeong LeeHLHee Jeong Lee
- Tae-Wan ChungTCTae-Wan Chung
- Seonhwa LeeSLSeonhwa Lee
- Jongmin HwangJHJongmin Hwang
- In-Cheol KimIKIn-Cheol Kim
- Yun-Kyeong ChoYCYun-Kyeong Cho
- Hyuck-Jun YoonHYHyuck-Jun Yoon
- Seung-Ho HurSHSeung-Ho Hur
- Jin Young KimJKJin Young Kim
- Yun Seok KimYKYun Seok Kim
- Woo Sung JangWJWoo Sung Jang
Open Access
- 1 January 2025
- journal article
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (5) , 396-407
Abstract
Lee CH, et al. Korean Circ J. 2025 Feb;55:e40. https://doi.org/10.4070/kcj.2024.0101Keywords
Funding Information
- Medtronic and Biosensors (Dio Medical in Korea)
This publication has 27 references indexed in Scilit:
- Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery DiseaseJACC, 2018
- Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS?JACC, 2017
- The State of the Absorb Bioresorbable ScaffoldJACC: Cardiovascular Interventions, 2017
- Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting StentsJACC: Cardiovascular Interventions, 2017
- Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total OcclusionsJACC: Cardiovascular Interventions, 2017
- Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal StentsJACC, 2014
- Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting StentsJACC: Cardiovascular Interventions, 2013
- Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery DiseaseJACC, 2011
- Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary ArteriesJACC, 2011
- Angiographic Surrogate End Points in Drug-Eluting Stent TrialsJACC, 2008